HomeNewsWorldSARS-related coronaviruses infect around 66,000 people a year in Southeast Asia: Study

SARS-related coronaviruses infect around 66,000 people a year in Southeast Asia: Study

The research, published by Nature Communications, said viral transmission from bats to humans may have been "substantially underestimated", adding that its mapping of bat species in the region could aid efforts to determine the origins of COVID-19.

August 10, 2022 / 10:39 IST
Story continues below Advertisement
Representative image (Image: AP)
Representative image (Image: AP)

About 66,000 people in Southeast Asia are infected each year with SARS-related coronaviruses, and nearly 500 million people live near habitats where bat hosts of those viruses are found, according to a study released on Wednesday.

The research, published by Nature Communications, said viral transmission from bats to humans may have been "substantially underestimated", adding that its mapping of bat species in the region could aid efforts to determine the origins of COVID-19.

Story continues below Advertisement

The researchers focused on 26 species of bat known to host SARS-like coronaviruses in a region of 5.1 million square kilometres (2 million square miles), stretching from China to Southeast and South Asia. They then incorporated data on antibody levels among people who have reported bat contact.

Southern China, northeastern Myanmar, Laos and northern Vietnam were identified as the regions with the highest diversity of bat species that host SARS-like coronaviruses (SARSr-CoVs).

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show